Figure 5.

The Sambucus nigra agglutinin/d‐galactose, N‐acetyl galactosamine (SNA/GalNAc‐L) binding ratio reflects glucocorticoid therapy. The studied cohort was divided into four groups according to the period of time receiving glucocorticoid therapy. The first group did not receive glucocorticoids during the whole observation period (steroid 0/0), patients starting glucocorticoid therapy after enrolment (steroid 0/1), patients who were treated with glucocorticoids at the time of inclusion but were withdrawn later (steroid 1/0) and patients receiving glucocorticoids during the whole study period (steroid 1/1). A significant increase of the SNA/GalNAc‐L binding ratio was observed only for the patients who were treated with glucocorticoids over the entire period.